ABSTRACT
Considering that the main neurobiological actions of ayahuasca are strongly related to 145 key physiological systems altered in major depression, and taking into account the low 
154
Our hypotheses are that patients and controls will show, in baseline, different levels of 155 plasma cortisol and awakening salivary cortisol response and the cortisol levels in patients 156 will be correlated with severity and/or duration of disease. Moreover, ayahuasca, but not 157 placebo, will increase cortisol levels acutely (43), during dosing session and after 48 hours 
METHODS

164
This is a randomized double-blinded placebo-controlled trial using a parallel arm design. 
Volunteers
174
Seventy-one volunteers participated in the study: 43 healthy volunteers, control group Rating Scale (MADRS). All patients were not using any antidepressant medication during 187 the trial, however they all were under regular use of benzodiazepines.
189
Volunteers from both groups (healthy and patients) were randomly assigned (1:1) to 190 receive ayahuasca or placebo using 10-gauge blocks. Half of the patients and half of the 
Ayahuasca and placebo
196
The substance used as placebo did not have psychoactive properties, but induced a light Saliva was collected using a specific cotton stick called Salivette (Sarstedt, Germany).
211
Volunteers were instructed to place the cotton in the mouth without touching and 212 masticating it for a period of about 1 to 2 minutes. Before and during collection subjects 213 remained at rest and no liquid or food were allowed.
215
Saliva samples were stored at -80ºC in the Laboratory of Hormonal Measures (UFRN) 216 and the salivary cortisol was measured using the ELISA DGR -SLV 4635 kit (DGR
217
International, Inc, Germany).
219
Plasma cortisol
221
Blood samples were collected in the morning (7:00 a.m), for total plasma cortisol (PC) 
240
clinicians in the screening phase that was followed by a pharmacological wash-out phase of approximately two weeks.
241
In D-1, all subjects, healthy volunteers of control group (C) and MD, slept at the hospital (internation) and plasma and 242 salivary cortisol at waking time, at D0, were collected. Also in D0 the dosing session happened, and subjects (C and 243 MD) were divided in two subgroups each, depending on placebo (PLA) or ayahuasca (AYA) intake. During dosing 244 session saliva was collected for cortisol measurement, 1h40 after intake. On D2 (48 hours after intake), again, plasma
245
and saliva collection at awake were performed for cortisol dosage. 
Statistical analysis 266 267
Statistical analysis was conducted in Statistic 12.5 (data analysis software system), and 268 the level of significance was set at p < 0.05 for all tests. Graphics were built in R 3.4.1 269 (RStudio).
271
The area under the curve (AUC) was calculated from the 3 points of salivary cortisol at For plasma cortisol, this same analysis was applied but sex was not used as independent 287 variable, because the number of male patients who received placebo was too small (n=2).
289
Acute response (%) of salivary cortisol during the dosing session were evaluated 1h40 290 after ayahuasca or placebo ingestion and assessed by Mann-Whitney test.
292
Moreover, Spearman correlations test were calculated across acute response (%) of 
RESULTS
299
Socio-demographic characteristics of healthy volunteers, control group (C), and patients 300 with major depression (MD) are summarized in Figure 2 shows the cortisol levels at baseline (D0). Figure 2a shows 
376
In baseline, the scores MADRS of patients were 32.67±6. 399 2 of suppl. material for details). 
449
GLM and post hoc Fisher, p <0.05.
451
No statically significant correlations were observed across plasma cortisol and AUC of conditions.
514
The etiology of hypocortisolism is explained by various theories. One of them shows that 515 a greater and decompensate sensitivity in negative feedback of the HPA axis deregulates 516 cortisol secretion (54). Also, hypocortisolism is associate to adrenal insufficiency, a 517 failure to produce cortisol and a decrease or increase in Adrenocorticotrophic hormone
518
(ACTH) concentrations that depend on the type of failure, whether primary or secondary, 519 respectively (48). New evidence also appoints the participation of paracrine and autocrine 520 messengers in adrenal failure (59). While several theories try to explain the etiology of 521 hypocortisolism, it seems that the best approach to elucidate this pathophysiological 522 process involves the integration of all these theories.
524
The regulation of cortisol is an important physiological aspect on the way of achieving The levels of cortisol in plasma and saliva, at baseline, was positively correlated for Binding Globulin), its protein of transportation in plasma (70).
554
During the acute effects of ayahuasca we found increased cortisol levels, 1h40 after AUC between controls and patients that were treated with ayahuasca points to a beneficial 573 modulation of ayahuasca on awakening salivary cortisol response.
575
Some studies with animal models of depression, rodents and non-human primates, However, more investigation are necessary, mainly chronic treatment studies.
612
Again, once more, our hypothesis was partially corroborated. As was hypothesized,
613
ayahuasca induced a large increase in acute salivary cortisol response than placebo. 
